Literature DB >> 10217593

Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium.

J T Voeten1, R Brands, A M Palache, G J van Scharrenburg, G F Rimmelzwaan, A D Osterhaus, E C Claas.   

Abstract

In the present study reassortant influenza A viruses of both the H1N1 and H3N2 type were generated in Madin Darby Canine Kidney cells grown in the absence of fetal bovine serum (MDCK-SF1 cells). To this end, MDCK-SF1 cells were simultaneously infected with one of the high-growth laboratory strains A/Puerto Rico/8/34 (H1N1) or A/Hong Kong/2/68 (H3N2) and recent H3N2 and H1N1 vaccine strains, respectively. Reassortant viruses obtained from these mixed infections were genetically characterized by RT-PCR and restriction enzyme analysis and their growth properties were compared to those of the corresponding field strains. Reassortant H3N2 viruses inherited the matrix and polymerase pa gene whilst H1N1 reassortant viruses inherited the matrix and polymerase pbl gene of the high-growth parent. Reassortant viruses generally gave higher viral yields, as measured by a haemagglutination assay, than their wild type counterparts. The procedure followed results in the generation of high-growth reassortant viruses in weeks. The use of MDCK-SF1 cells together with these reassortants for generating influenza virus antigens can significantly speed up the vaccine production procedure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10217593     DOI: 10.1016/s0264-410x(98)00464-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Imparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A/Ann Arbor/6/60.

Authors:  Hong Jin; Helen Zhou; Bin Lu; George Kemble
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

2.  Development of avian influenza virus H5 DNA vaccine and MDP-1 gene of Mycobacterium bovis as genetic adjuvant.

Authors:  Babak Jalilian; Abdul Rahman Omar; Mohd Hair Bejo; Noorjahan Banu Alitheen; Mehdi Rasoli; Sohkichi Matsumoto
Journal:  Genet Vaccines Ther       Date:  2010-05-24

3.  Genetic content of Influenza H3N2 vaccine seeds.

Authors:  Corinne Bergeron; Martine Valette; Bruno Lina; Michele Ottmann
Journal:  PLoS Curr       Date:  2010-09-05

4.  Quantitation of influenza virus using field flow fractionation and multi-angle light scattering for quantifying influenza A particles.

Authors:  Tatiana Bousse; David A Shore; Cynthia S Goldsmith; M Jaber Hossain; Yunho Jang; Charles T Davis; Ruben O Donis; James Stevens
Journal:  J Virol Methods       Date:  2013-07-31       Impact factor: 2.014

5.  Transient expression of hemagglutinin antigen from low pathogenic avian influenza A (H7N7) in Nicotiana benthamiana.

Authors:  Selvaraju Kanagarajan; Conny Tolf; Anneli Lundgren; Jonas Waldenström; Peter E Brodelius
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

Review 6.  Current and emerging cell culture manufacturing technologies for influenza vaccines.

Authors:  Ernest Milián; Amine A Kamen
Journal:  Biomed Res Int       Date:  2015-03-01       Impact factor: 3.411

7.  Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza.

Authors:  Aziza P Manceur; Wei Zou; Anne Marcil; Eric Paquet; Christine Gadoury; Bozena Jaentschke; Xuguang Li; Emma Petiot; Yves Durocher; Jason Baardsnes; Manuel Rosa-Calatrava; Sven Ansorge; Amine A Kamen
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

8.  Downstream Processing: From Egg to Cell Culture-Derived Influenza Virus Particles.

Authors:  M W Wolff; U Reichl
Journal:  Chem Eng Technol       Date:  2008-05-27       Impact factor: 1.728

9.  Growth characteristics of canine pathogenic viruses in MDCK cells cultured in RPMI 1640 medium without animal protein.

Authors:  Masami Mochizuki
Journal:  Vaccine       Date:  2005-10-25       Impact factor: 3.641

10.  Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.

Authors:  Rogier Bodewes; Joost H C M Kreijtz; Chantal Baas; Martina M Geelhoed-Mieras; Gerrie de Mutsert; Geert van Amerongen; Judith M A van den Brand; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  PLoS One       Date:  2009-05-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.